# BEO Pharma Inc – FDA Inspection, Sep 18, 2026

Source: https://www.keypedia.com/records/fda_inspections/beo-pharma-inc/19e1311a-bde9-484c-9ebd-ff49e147a1b0
Source feed: FDA_Inspections

> FDA inspection 1337028 of BEO Pharma Inc, September 18, 2026. 5 citations under 21 CFR part 211. Form 483 issued. 1 other FDA inspection on record for this company.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1337028
- Company Name: BEO Pharma Inc
- Inspection Date: 2026-09-18
- Project Area: Drug Quality Assurance
- Product Type: Human Drugs
- Center: Human Drugs
- Office Name: Florida District Office
- Citation Count: 5

## Related Documents

- [FDA Inspection 1253295 - 2024-11-04](https://www.keypedia.com/records/fda_inspections/beo-pharma-inc/e258df89-955c-4c64-bc54-2dbe54610e44)

## Related Officers

- [Issuing Officer](https://www.keypedia.com/people/ashley-n-samuel/f98c1579-bf33-499e-89d0-62e394e6ee91)
- [FDA Associated Person](https://www.keypedia.com/people/saundrea-a-munroe/129a869f-e1f2-4d59-b3ed-9613a9190f8a)

Company: https://www.keypedia.com/companies/beo-pharma-inc/bc2943c1-de0c-4bf5-b29b-49563229a8fb

Office: https://www.keypedia.com/offices/florida-district-office/95b2a118-0b78-46e0-a54c-982bd7ce51c9